Literature DB >> 2307535

Body mass index and risk of breast cancer. A prospective study of 23,826 Norwegian women.

L J Vatten1, S Kvinnsland.   

Abstract

The association between body mass index (BMI) and the incidence rate of breast cancer has been examined in 236 cases of breast cancer that developed among 23,826 Norwegian women during 11 to 14 years of follow-up. At the time of height and weight measurement they were 35 to 51 years of age, and at the end of follow-up their age was between 46 and 63 years. There was an overall age-adjusted incidence rate ratio (IRR) of 0.52 (95% confidence limits, 0.34 and 0.77) for women in the highest quartile of BMI compared to women in the lowest quartile, which was confined to an effect observed among women who were diagnosed at age 50 or earlier (IRR = 0.36). The association with BMI displayed an inverse dose-related trend (chi 2 for trend = 14.22, p less than 0.001). The negative trend was particularly pronounced among non-smoking women (chi 2 = 14.63), and no clear trend associate with BMI was observed among women who smoked 10 or more cigarettes per day (chi 2 = 0.41), indicating an interaction between BMI and cigarette smoking (chi 2 interaction = 3.86, p = 0.05). We thus suggest that there is a negative association between body mass index and risk of breast cancer among premenopausal women.

Entities:  

Mesh:

Year:  1990        PMID: 2307535     DOI: 10.1002/ijc.2910450311

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  Challenges for public health nutrition in the 1990s.

Authors:  W Willett
Journal:  Am J Public Health       Date:  1990-11       Impact factor: 9.308

2.  Anthropometric measures and breast cancer in young women.

Authors:  E Lund; H O Adami; R Bergstrøm; O Meirik
Journal:  Cancer Causes Control       Date:  1990-09       Impact factor: 2.506

3.  Obesity and its relation to cardiovascular disease risk factors in Canadian adults. Canadian Heart Health Surveys Research Group.

Authors:  B A Reeder; A Angel; M Ledoux; S W Rabkin; T K Young; L E Sweet
Journal:  CMAJ       Date:  1992-06-01       Impact factor: 8.262

4.  Body fat distribution and risk of premenopausal breast cancer in the Nurses' Health Study II.

Authors:  Holly R Harris; Walter C Willett; Kathryn L Terry; Karin B Michels
Journal:  J Natl Cancer Inst       Date:  2010-12-16       Impact factor: 13.506

5.  A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics.

Authors:  L N Kolonel; B E Henderson; J H Hankin; A M Nomura; L R Wilkens; M C Pike; D O Stram; K R Monroe; M E Earle; F S Nagamine
Journal:  Am J Epidemiol       Date:  2000-02-15       Impact factor: 4.897

6.  Risk of prostate, ovarian, and endometrial cancer among relatives of women with breast cancer.

Authors:  H Tulinius; V Egilsson; G H Olafsdóttir; H Sigvaldason
Journal:  BMJ       Date:  1992-10-10

7.  The epidemiological profile of women with an interval cancer in the DOM screening programme.

Authors:  C T Brekelmans; P H Peeters; J A Faber; J J Deurenberg; H J Collette
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

8.  Association between body mass index and risk of breast cancer in Tunisian women.

Authors:  Awatef Msolly; Msolly Awatef; Olfa Gharbi; Gharbi Olfa; Kacem Mahmoudi; Mahmoudi Kacem; Sami Limem; Limem Sami; Makram Hochlef; Hochlef Makram; Slim Ben Ahmed; Ben Ahmed Slim
Journal:  Ann Saudi Med       Date:  2011 Jul-Aug       Impact factor: 1.526

9.  Possible association of beta2- and beta3-adrenergic receptor gene polymorphisms with susceptibility to breast cancer.

Authors:  X E Huang; N Hamajima; T Saito; K Matsuo; M Mizutani; H Iwata; T Iwase; S Miura; T Mizuno; S Tokudome; K Tajima
Journal:  Breast Cancer Res       Date:  2001-04-26       Impact factor: 6.466

10.  Relationship between Quetelet's index and cancer of breast and female genital tract in 47,000 women followed for 25 years.

Authors:  S A Törnberg; J M Carstensen
Journal:  Br J Cancer       Date:  1994-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.